Analysts/Institutional Investor Meet/Con. Call Updates

Date: November 02, 2026 BSE Limited (‘BSE’) National Stock Exchange of India Ltd Listing Department Exchange Plaza, Corporate Relationship Bandra-Kurla Complex, Department Bandra (E), Mumbai 400 051 Phiroze Jeejeebhoy Towers, Symbol: MOLBIO 2nd Floor, Dalal Street, Mumbai – 400 001 BSE Script Code: 544866 Subject: Intimation of Earnings Conference Call under Regulation 30 and all other applicable regulations, if any, of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, the Company has scheduled an Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. The invitation for Earnings Conference Call is enclosed. The above disclosure is also being made available on the website of the Company at https://www.molbiodiagnostics.com. You are requested to kindly take the same on record. Thanking You. Yours Faithfully, For Molbio Diagnostics Limited Darshan Raghunath Karekar Company Secretary & Compliance Officer M.No: F13569 Place: Verna-Goa Enclosure: Invitation for Earnings Conference Call. Zoom Link https://us06web.zoom.us/webinar/register/WN_H6clLek1SFi97s5CRZmrUA The Management of Molbio Diagnostics Limited invites you to the Management Participants Q2 & H1 FY27 Earnings • Sriram Natarajan - Executive Director & Chief Executive Officer Conference Call • Dr Chandrasekhar Nair - Executive Director & Chief Technology Officer • Shiva Sriram - President – Business Development To discuss the performance for the • Manan Bimal Khokhani- President, Finance and Accounts & CFO quarter and half year ended September 30, 2026 • Indraneil Borkakoty - President – Corporate Strategy, Mergers & Acquisitions and IR DATE: Thursday, 5ᵗʰ Nov, 2026 Participants are requested to join the link 5 minutes in advance For more information please contact: TIME: 05:30 PM IST IndraneilBorkakoty Smit Shah / Anand Venugopal President –Corporate Strategy, Mergers & +91 98707 89596 / +91 70218 52071 Acquisitions and IR smit.shah@adfactorspr.com/ anand.venugopal@adfactorspr.com indraneil.borkakoty@molbiodiagnostics.com